Estarol Duo (Ezetimibe & Atorvastatin)

Product Description

Estarol Duo is an advanced combination of two active ingredients, Ezetimibe and Atorvastatin, developed by Crassula Pharma . Designed to provide effective cholesterol control and improve cardiovascular health.


This medication represents an advance in the treatment of hypercholesterolemia and the reduction of cardiovascular risk.



Crassula Pharmaceuticals

  • US
  • 2023
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
Distributor/Import Export
Manufacturer/Innovator
Pharmaceutical company
Wholesale/Retail
Primary activities
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Nutraceuticals
Pharmaceutical Company (generic finished products)
Specifications
  • Details
    Estarol Duo is available in different doses to adapt to the needs of each patient: Ezetimibe USP 10mg + Atorvastatin USP 10mg and Ezetimibe USP 10mg + Atorvastatin USP 20mg

  • Selling Points
    Brand Name; Cardiovascular Health; Product Performance; Quality Service
  • Supplied from
    India
  • Measured In
    milligram

Crassula Pharmaceuticals

  • US
  • 2023
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
Distributor/Import Export
Manufacturer/Innovator
Pharmaceutical company
Wholesale/Retail
Primary activities
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Nutraceuticals
Pharmaceutical Company (generic finished products)

More Products from Crassula Pharmaceuticals (2)

  • Glycedil ( Sitagliptin )

    Product Glycedil ( Sitagliptin )

    Sitagliptin is used along with diet and exercise and sometimes with other medications to lower blood sugar levels in adults with type 2 diabetes (condition in which blood sugar is too high because the body does not produce or use insulin normally). Sitagliptin is in a class of medications called dipeptidyl...
  • Relixib ( Etoricoxib )

    Product Relixib ( Etoricoxib )

    Etoricoxib, the active ingredient in Relixib, belongs to a class of medications known as selective COX-2 inhibitors, offering targeted relief from pain and swelling associated with various arthritic conditions, including osteoarthritis, rheumatoid arthritis, and gout. The 120mg dosage has been carefully se...

Crassula Pharmaceuticals resources (2)

  • News Crassula Pharmaceuticals Launches Relixib, Etoricoxib 120mg, in Honduras

    Tegucigalpa, Honduras – Crassula Honduras, a leading pharmaceutical manufacturer renowned for its commitment to quality, is excited to announce the introduction of Relixib, an etoricoxib 120mg tablet, to the Honduran market. This new addition to Crassula’s portfolio reinforces the company’s dedication to providing advanced healthcare solutions and addressing the needs of patients suffering from chronic pain and inflammation.
  • Video Tablet and Capsule manufacturing plant.

    Our facilities are equipped with the latest and most sophisticated equipment and technology. Adhering to ISO 9001:2015 and ISO 14001:2015 standards, we comply with the latest WHO norms and GMP, ensuring the highest quality in all our products